Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019
Open Access
- 15 August 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (8), e0273097
- https://doi.org/10.1371/journal.pone.0273097
Abstract
Severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2 infection in children and adolescents primarily causes mild or asymptomatic coronavirus disease 2019 (COVID-19), and severe illness is mainly associated with comorbidities. However, the worldwide prevalence of COVID-19 in this population is only 1%–2%. In Mexico, the prevalence of COVID-19 in children has increased to 10%. As serology-based studies are scarce, we analyzed the clinical features and serological response (SARS-CoV-2 structural proteins) of children and adolescents who visited the Hospital Infantil de México Federico Gómez (October 2020–March 2021). The majority were 9-year-old children without comorbidities who were treated as outpatients and had mild-to-moderate illness. Children aged 6–10 years and adolescents aged 11–15 years had the maximum number of symptoms, including those with obesity. Nevertheless, children with comorbidities such as immunosuppression, leukemia, and obesity exhibited the lowest antibody response, whereas those aged 1–5 years with heart disease had the highest levels of antibodies. The SARS-CoV-2 spike receptor-binding domain-localized peptides and M and E proteins had the best antibody response. In conclusion, Mexican children and adolescents with COVID-19 represent a heterogeneous population, and comorbidities play an important role in the antibody response against SARS-CoV-2 infection.Funding Information
- Hospital Infantil de México Federico Gómez (HIM-2020-029)
- Hospital Infantil de México Federico Gómez (HIM-2020-060)
- Hospital Infantil de México Federico Gómez (HIM-2021-007)
This publication has 49 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- A novel coronavirus outbreak of global health concernThe Lancet, 2020
- Coronavirus envelope protein: current knowledgeVirology Journal, 2019
- The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent MechanismmBio, 2016
- Serological assays for emerging coronaviruses: Challenges and pitfallsVirus Research, 2014
- A structural analysis of M protein in coronavirus assembly and morphologyJournal of Structural Biology, 2011
- The membrane protein of SARS‐CoV suppresses NF‐κB activationJournal of Medical Virology, 2007
- Coronavirus envelope protein: A small membrane protein with multiple functionsCellular and Molecular Life Sciences, 2007
- Supramolecular Architecture of Severe Acute Respiratory Syndrome Coronavirus Revealed by Electron CryomicroscopyJournal of Virology, 2006
- Nucleocapsid-Independent Specific Viral RNA Packaging via Viral Envelope Protein and Viral RNA SignalJournal of Virology, 2003